← Back to headlines
Pfizer's Lyme Vaccine Effective in Study, Company Seeks FDA Approval
Pfizer and French partner Valneva announced their Lyme disease vaccine candidate was effective in a study, leading them to move forward with plans to seek regulatory approval from the FDA.
23 Mar, 11:51 — 23 Mar, 13:36
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left1
Left (1)
cnbc
Center1
Center (1)
bloomberg
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 2 of 3 sources
cnbcMostly Factual1h ago
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
Read full article →seeking-alphaMixed3h ago
Pfizer, Valneva SE report phase 3 results for Lyme vaccine candidate
Read full article →Coverage Timeline
First report: seeking-alpha · 23 Mar, 11:51|Full coverage: 3 · 2h|Window: 2h
